299 related articles for article (PubMed ID: 26573395)
1. Differences in the function and secretion of congenital aberrant fibrinogenemia between heterozygous γD320G (Okayama II) and γΔN319-ΔD320 (Otsu I).
Mukai S; Ikeda M; Takezawa Y; Sugano M; Honda T; Okumura N
Thromb Res; 2015 Dec; 136(6):1318-24. PubMed ID: 26573395
[TBL] [Abstract][Full Text] [Related]
2. Recombinant γT305A fibrinogen indicates severely impaired fibrin polymerization due to the aberrant function of hole 'A' and calcium binding sites.
Ikeda M; Kobayashi T; Arai S; Mukai S; Takezawa Y; Terasawa F; Okumura N
Thromb Res; 2014 Aug; 134(2):518-25. PubMed ID: 24968960
[TBL] [Abstract][Full Text] [Related]
3. Genetic analyses of novel compound heterozygous hypodysfibrinogenemia, Tsukuba I: FGG c.1129+62_65 del AATA and FGG c.1299+4 del A.
Mukai S; Nagata K; Ikeda M; Arai S; Sugano M; Honda T; Okumura N
Thromb Res; 2016 Dec; 148():111-117. PubMed ID: 27837696
[TBL] [Abstract][Full Text] [Related]
4. In vitro expression demonstrates impaired secretion of the gammaAsn319, Asp320 deletion variant fibrinogen.
Kani S; Terasawa F; Lord ST; Tozuka M; Ota H; Okumura N; Katsuyama T
Thromb Haemost; 2005 Jul; 94(1):53-9. PubMed ID: 16113784
[TBL] [Abstract][Full Text] [Related]
5. Heterozygous variant fibrinogen γA289V (Kanazawa III) was confirmed as hypodysfibrinogenemia by plasma and recombinant fibrinogens.
Kaido T; Yoda M; Kamijo T; Taira C; Higuchi Y; Okumura N
Int J Lab Hematol; 2020 Apr; 42(2):190-197. PubMed ID: 31957968
[TBL] [Abstract][Full Text] [Related]
6. In vitro fibrin clot formation and fibrinolysis using heterozygous plasma fibrinogen from gammaAsn319, Asp320 deletion dysfibrinogen, Otsu I.
Terasawa F; Kani S; Hongo M; Okumura N
Thromb Res; 2006; 118(5):651-61. PubMed ID: 16412498
[TBL] [Abstract][Full Text] [Related]
7. Recombinant γY278H Fibrinogen Showed Normal Secretion from CHO Cells, but a Corresponding Heterozygous Patient Showed Hypofibrinogenemia.
Kamijo T; Kaido T; Yoda M; Arai S; Yamauchi K; Okumura N
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069309
[TBL] [Abstract][Full Text] [Related]
8. A C-terminal amino acid substitution in the gamma-chain caused by a novel heterozygous frameshift mutation (Fibrinogen Matsumoto VII) results in hypofibrinogenaemia.
Fujihara N; Haneishi A; Yamauchi K; Terasawa F; Ito T; Ishida F; Okumura N
Thromb Haemost; 2010 Aug; 104(2):213-23. PubMed ID: 20589319
[TBL] [Abstract][Full Text] [Related]
9. Comparison of thrombin-catalyzed fibrin polymerization and factor XIIIa-catalyzed cross-linking of fibrin among three recombinant variant fibrinogens, gamma 275C, gamma 275H, and gamma 275A.
Hirota-Kawadobora M; Terasawa F; Suzuki T; Tozuka M; Sano K; Okumura N
J Thromb Haemost; 2004 Aug; 2(8):1359-67. PubMed ID: 15304042
[TBL] [Abstract][Full Text] [Related]
10. Novel variant fibrinogen γp.C352R produced hypodysfibrinogenemia leading to a bleeding episode and failure of infertility treatment.
Yoda M; Kaido T; Kamijo T; Taira C; Higuchi Y; Arai S; Okumura N
Int J Hematol; 2021 Sep; 114(3):325-333. PubMed ID: 34117991
[TBL] [Abstract][Full Text] [Related]
11. Congenital fibrinogen disorder with a compound heterozygote possessing two novel FGB mutations, one qualitative and the other quantitative.
Yoda M; Kaido T; Taira C; Higuchi Y; Arai S; Okumura N
Thromb Res; 2020 Dec; 196():152-158. PubMed ID: 32871307
[TBL] [Abstract][Full Text] [Related]
12. An engineered fibrinogen variant AαQ328,366P does not polymerise normally, but retains the ability to form α cross-links.
Park R; Ping L; Song J; Seo JY; Choi TY; Choi JR; Gorkun OV; Lord ST
Thromb Haemost; 2013 Feb; 109(2):199-206. PubMed ID: 23224113
[TBL] [Abstract][Full Text] [Related]
13. Three cases of congenital dysfibrinogenemia in unrelated Chinese families: heterozygous missense mutation in fibrinogen alpha chain Argl6His.
Luo M; Deng D; Xiang L; Cheng P; Liao L; Deng X; Yan J; Lin F
Medicine (Baltimore); 2016 Sep; 95(39):e4864. PubMed ID: 27684817
[TBL] [Abstract][Full Text] [Related]
14. Fibrinogen residue γAla341 is necessary for calcium binding and 'A-a' interactions.
Park R; Ping L; Song J; Hong SY; Choi TY; Choi JR; Gorkun OV; Lord ST
Thromb Haemost; 2012 May; 107(5):875-83. PubMed ID: 22437918
[TBL] [Abstract][Full Text] [Related]
15. Fibrinogen Mahdia: A congenitally abnormal fibrinogen characterized by defective fibrin polymerization.
Amri Y; Jouini H; Becheur M; Dabboubi R; Mahjoub B; Messaoud T; Sfar MT; Casini A; de Moerloose P; Toumi NEH
Haemophilia; 2017 Jul; 23(4):e340-e347. PubMed ID: 28594476
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of fibrinogen synthesis and secretion between novel variant fibrinogen, nagakute (gamma305Thr --> Ala), and other variants located in gamma305-308 residues].
Kobayashi T; Takezawa Y; Terasawa F; Okumura N
Rinsho Byori; 2012 Sep; 60(9):831-8. PubMed ID: 23157111
[TBL] [Abstract][Full Text] [Related]
17. Two novel mutations in the fibrinogen γ nodule.
Kotlín R; Pastva O; Stikarová J; Hlaváčková A; Suttnar J; Chrastinová L; Riedel T; Salaj P; Dyr JE
Thromb Res; 2014 Oct; 134(4):901-8. PubMed ID: 25074738
[TBL] [Abstract][Full Text] [Related]
18. Recombinant variant fibrinogens substituted at residues gamma326Cys and gamma339Cys demonstrated markedly impaired secretion of assembled fibrinogen.
Haneishi A; Terasawa F; Fujihara N; Yamauchi K; Okumura N; Katsuyama T
Thromb Res; 2009 Jul; 124(3):368-72. PubMed ID: 19419756
[TBL] [Abstract][Full Text] [Related]
19. Nonsense-mediated mRNA decay was demonstrated in two hypofibrinogenemias caused by heterozygous nonsense mutations of FGG, Shizuoka III and Kanazawa II.
Soya K; Takezawa Y; Okumura N; Terasawa F
Thromb Res; 2013 Oct; 132(4):465-70. PubMed ID: 24011387
[TBL] [Abstract][Full Text] [Related]
20. Heterozygous Bβ-chain C-terminal 12 amino acid elongation variant, BβX462W (Kyoto VI), showed dysfibrinogenemia.
Okumura N; Terasawa F; Takezawa Y; Hirota-Kawadobora M; Inaba T; Fujita N; Saito M; Sugano M; Honda T
Blood Coagul Fibrinolysis; 2012 Jan; 23(1):87-90. PubMed ID: 22001526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
